Application study of quick cognitive screening test in identifying mild cognitive impairment

Area of Science:

• Neurology
• Geriatrics
• Cognitive Science

Background:

• Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
• Early detection of MCI is crucial for timely intervention and management.
• Existing screening tools may require further validation for broad clinical application.

Purpose of the Study:

• To evaluate the diagnostic accuracy of the Quick Cognitive Screening Test (QCST) for identifying individuals with MCI.
• To compare the performance of QCST against established neuropsychological assessments.

Main Methods:

• A cross-sectional study involving 121 MCI cases (amnestic and nonamnestic subtypes), 79 mild Alzheimer's disease (AD) patients, and 186 healthy elderly controls.
• Participants aged 55-85 with at least 5 years of education underwent QCST and standardized tests like MMSE and MoCA.
• QCST comprises subtests assessing memory, naming, fluency, attention, and visuospatial skills, with a total score of 90 points.

Main Results:

• The mean QCST scores were significantly different across groups: MCI (58.13±8.18), AD (44.53±10.54), and controls (72.92±6.85).
• Adjusted cutoff scores based on education levels ranged from 63 to 68 points.
• QCST demonstrated high sensitivity (87.6%) and specificity (84.3%) for MCI detection, with an AUC of 0.923.

Conclusions:

• The Quick Cognitive Screening Test (QCST) exhibits favorable sensitivity and specificity for detecting mild cognitive impairment (MCI).
• These findings support the potential clinical utility of QCST for rapid cognitive screening.
• Further research and validation are warranted for its broader implementation in clinical practice.